About CRYSTALNEURO LLC
CrystalNeuro is a Connecticut-based biotech company established in 2020, focused on developing a nanotechnology-based diagnostic kit for the early detection of neurodegenerative diseases such as Alzheimer’s Disease. The company has filed a patent with the USPTO in December 2021.
Development of nanotechnology-based diagnostic kits for early detection of neurodegenerative diseasesBiomarker detection using nanomaterials for early identification of Alzheimer’s DiseaseNanoparticle-based detection and treatment platforms for tracking biomarkers in the brain and cerebrospinal fluidResearch and development in biotechnology and pharmaceutical fieldsConsulting in life science fields and biomedical/medical/scientific translation
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CRYSTALNEURO LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.